Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 151–159 of 159 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03980535	New Magnetic Resonance Imaging and Spectroscopy Software in the Improvement of Image Quality	completed	N/A	273	M.D. Anderson Cancer CenterOTHER	1	Oct 28, 2022	clinicaltrials
NCT04759183	Virtual Reality Experiences for Anxiety and Pain Control	completed	N/A	32	OHSU Knight Cancer InstituteOTHER	1	Sep 7, 2022	clinicaltrials